Cargando…
A Threshold Model for T-Cell Activation in the Era of Checkpoint Blockade Immunotherapy
Continued discoveries of negative regulators of inflammatory signaling provide detailed molecular insights into peripheral tolerance and anti-tumor immunity. Accumulating evidence indicates that peripheral tolerance is maintained at multiple levels of immune responses by negative regulators of proin...
Autores principales: | Guram, Kripa, Kim, Sangwoo S., Wu, Victoria, Sanders, P. Dominick, Patel, Sandip, Schoenberger, Stephen P., Cohen, Ezra E. W., Chen, Si-Yi, Sharabi, Andrew B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431643/ https://www.ncbi.nlm.nih.gov/pubmed/30936880 http://dx.doi.org/10.3389/fimmu.2019.00491 |
Ejemplares similares
-
Radiation Therapy Combined With Checkpoint Blockade Immunotherapy for Metastatic Undifferentiated Pleomorphic Sarcoma of the Maxillary Sinus With a Complete Response
por: Guram, Kripa, et al.
Publicado: (2018) -
Further Advances in Cancer Immunotherapy: Going Beyond Checkpoint Blockade
por: Wilkinson, Robert W., et al.
Publicado: (2018) -
Combinational Immunotherapy for Hepatocellular Carcinoma: Radiotherapy, Immune Checkpoint Blockade and Beyond
por: Lee, Yun Hua, et al.
Publicado: (2020) -
Combinatorial blockade for cancer immunotherapy: targeting emerging immune checkpoint receptors
por: Roy, Dia, et al.
Publicado: (2023) -
Radiation Recall Pneumonitis After Treatment With Checkpoint Blockade Immunotherapy: A Case Series and Review of Literature
por: Riviere, Paul, et al.
Publicado: (2021)